The USPTO has posted its memorandum to the examining corps following the Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals decision. The memorandum is available [here].
The oral argument at the Federal Circuit is available below:
This entry was posted on Monday, June 18th, 2018 at 2:44 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.